News that has caught Rachael Babin’s eye this week
Browsing: Editor’s Choice
NICE recommends abiraterone for prostate cancer
NICE has issued final guidance recommending abiraterone (marketed as Zytiga by Janssen) for some prostate…
High coronary calcium score may signal increased risk of cancer and other diseases
A 10-year follow-up study of more than 6,000 people who underwent heart CT scans suggests…
World-first Australian prostate cancer trial will harness new technology to dramatically reduce treatment time for men
Australian researchers have launched the TROG 15.01 SPARK clinical trial, which will use revolutionary KIM…
Peter Mac trial of a new vaccine to prevent recurrence of colorectal cancer
Peter MacCallum Cancer Centre welcomes the announcement of the 2016 Victorian Cancer Agency grants, which…
Radiation combined with immune-stimulating drugs could pack a powerful punch against cancer cells
By Charlie Garnett Benson – Georgia State University. In his final State of the Union address, President Obama…
Researchers prevent and normalise tumours using light to control cell electric signals
Tufts University biologists using a frog model have demonstrated for the first time that it…
Why some tumours withstand treatment
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a…
Splenda Probably Doesn’t Cause Leukaemia
By Josh L Davis – IFL Science. A team of researchers from the Ramazzini Institute…
Drug combination shrinks HER2 positive breast cancers within 11 days
A drug combination – of lapatinib and trastuzumab (Herceptin) – before surgery shrinks tumours in women with HER2 positive…
Diabetes treatment can reduce mammographic density, an important risk factor for breast cancer
The use of diabetes treatment, whether by diet or pills such as metformin, decreases mammographic…